Aramark says ‘new business pipeline across the organization is significant’

In fiscal 2025, Aramark (ARMK) capitalized on extensive new business opportunities, resulting in annualized gross new business wins of $1.6B-more than 12% greater than fiscal 2024. The company also achieved a client retention rate of 96.3% with many LOBs and countries even higher. Combined, this represented unprecedented annualized Net New business for the company at 5.6% of prior year revenue, which included the largest contract win ever awarded in FSS United States history-and is also one of the most prestigious medical systems in the world-scheduled to commence operations early in the new year. Aramark believes in its continued ability to achieve Net New business of at least 4% to 5% of prior year revenue-with retention levels above 95%. The new business pipeline across the organization is significant, including in first-time outsourcing, and Aramark is already off to another strong start at this early stage in the new fiscal year. The company is also focused on accelerating profitability from its multiple operating levers, which include differentiated supply chain capabilities and disciplined cost management, building upon Aramark’s efficiencies and scale.